FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

15 letters match. Newest first.

  1. Cheap Medicine Shop/www.cheapmedicineshop.com

    FDA warned India-based website Cheap Medicine Shop for selling unapproved, misbranded injectable semaglutide to U.S. consumers.

    High risk
  2. Buy Keta Online / www.buyketaonline.com

    FDA warns Buy Keta Online that its website sells unapproved and misbranded ketamine drugs to U.S. consumers.

    High risk
  3. ketaminetroches.com

    FDA warns ketaminetroches.com that it sells unapproved and misbranded ketamine troches to U.S. consumers online.

    High risk
  4. Roen Health, Inc. dba RoenRx

    FDA warned RoenRx that its website misbrands compounded semaglutide with misleading approval claims and a company label implying it makes the drug.

    Medium
  5. Joi and Blokes dba Joi + Blokes

    FDA warned telehealth seller Joi + Blokes that its website misbrands compounded semaglutide and tirzepatide with false, misleading claims.

    Medium
  6. MEDVi, LLC dba MEDVi

    FDA says telehealth seller MEDVi misbranded compounded semaglutide and tirzepatide by implying MEDVi makes them and that they are FDA-approved.

    Medium
  7. AceCosm

    AceCosm’s website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.

    High risk
  8. Dermax Co., Ltd

    FDA warned China's Dermax Co., Ltd. over its website selling unapproved, misbranded injectable botulinum toxin to U.S. consumers.

    High risk
  9. Elle Pharm

    FDA warned Elle Pharm that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.

    High risk
  10. Glam Derma

    FDA warns Glam Derma over website selling unapproved, misbranded injectable botulinum toxin products.

    High risk
  11. www.plakini-pharma.com

    FDA warned Malaysia-based website plakini-pharma.com for selling unapproved, misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  12. www.trinexpharmacy.com

    FDA warned trinexpharmacy.com for selling unapproved tramadol and misbranded Adderall without prescriptions to U.S. consumers.

    High risk
  13. Tramadol US

    FDA warned Tramadol US for selling unapproved, misbranded opioid and benzodiazepine drugs, including tramadol, oxymorphone, and alprazolam, over the internet.

    High risk
  14. www.wellerectile.com

    FDA warned India-based www.wellerectile.com over selling unapproved, improperly labeled drugs online, including hydroxychloroquine claimed to treat COVID-19.

    High risk
  15. rxshopmd.com

    FDA warned rxshopmd.com, a Cyprus website, for selling unapproved and misbranded drugs, including lopinavir/ritonavir, to U.S. consumers online.

    High risk